6Stenmark K R, McMurtry I F. Vascular remodeling versus vasocon- striction in chronic hypoxic pulmonary hypertension: a time for reap- praisal? [J]. Circ Res, 2005, 97(2) : 95 -98.
7Nakamura Y, Morishita R, Higaki J, et al. Expression of local hepa- tocyte growth factor system in vascular tissues [ J ]. Biochem Biophys Res Commun, 1995, 215(2) : 483 -488.
8Nakamura Y, Morishita R, Higaki J, et al. Hepatocyte growth factor is a novel member of the endothelium-specifie growth factors : additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor [ J ]. J Hypertens, 1996, 14(9): 1067- 1072.
9Rabinovitch M. Elastase and cell matrix interactions in the pathobiolo- gy of vascular disease[ J]. Acta Paediatr Jpn, 1995, 37 (6) : 657 - 666.
10Pepper M S, Ferrara N, Orci L, et al. Potent synergism between vas- cular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro [ J ]. Biochem Biophys Res Com mun, 1992, 189(2) : 824 -831.
